OSI Systems, Inc. Form 10-Q Summary
Business Context and Reporting Period
OSI Systems designs and manufactures specialized electronic systems and components for homeland security, healthcare, defense, aerospace, and related markets. Its reporting segments are Security, Healthcare, and Optoelectronics and Manufacturing.
This quarterly report covers the three and six months ended December 31, 2015, representing fiscal 2016 second-quarter and year-to-date results. Comparative periods ended December 31, 2014. Financial statements are unaudited and prepared under U.S. GAAP.
Key Financial Metrics
| Metric | Three Months Ended Dec. 31 | Six Months Ended Dec. 31 |
|---|---|---|
| Net revenue | $197.3 million, down 23% | $397.4 million, down 17% |
| Gross profit | $68.1 million | $136.0 million |
| Gross margin | 34.5% | 34.2% |
| Operating income | $0.8 million | $16.5 million |
| Net income | $0.1 million | $10.9 million |
| Diluted EPS | $0.01 | $0.53 |
| Cash flow from operations | Not separately provided | $19.6 million |
For the quarter, operating margin was approximately 0.4% and net margin was approximately 0.1%. For the six-month period, operating margin was approximately 4.1% and net margin was approximately 2.7%.
At December 31, 2015, cash and cash equivalents were $79.8 million, compared with $47.6 million at June 30, 2015. Total debt, including bank lines of credit and current and long-term debt, was approximately $65.0 million, compared with $11.4 million at June 30, 2015. The company had $55.0 million outstanding under its $450 million revolving credit facility and $6.1 million of letters of credit outstanding.
Inventory increased to $280.6 million from $230.4 million at June 30, 2015. Accounts receivable declined to $157.8 million from $178.5 million. Total assets were $1.01 billion and total liabilities were $442.8 million at December 31, 2015.
Material Changes Versus the Prior Comparable Period
- Quarterly revenue declined $60.5 million, primarily because Security revenue fell $43.3 million. The decrease included a $38.4 million reduction from a significant Foreign Military Sale contract with the U.S. Department of Defense, substantially completed in fiscal 2015.
- Year-to-date revenue declined $78.8 million. Security revenue decreased $60.3 million, including a $51.4 million reduction from the same FMS contract and approximately $9 million of prior-year revenue related to security equipment for the Glasgow 2014 Commonwealth Games.
- Healthcare revenue declined 20% for the quarter and 9% year to date, with weakness across most product lines and regions, which management attributed to challenging economic conditions.
- Optoelectronics and Manufacturing revenue declined 7% for the quarter and 9% year to date, primarily due to lower OEM contract-manufacturing volumes, lower commercial optoelectronics deliveries, and reduced intercompany sales to Healthcare.
- Gross margins were broadly stable despite lower revenue: 34.5% versus 34.6% for the quarter and 34.2% versus 34.3% year to date.
- Operating income fell from $26.1 million to $0.8 million for the quarter and from $42.7 million to $16.5 million year to date. The decline reflected lower sales and $11.1 million of impairment, restructuring, and other charges in 2015 versus $2.1 million for the comparable quarter.
- The 2015 charges included $5.9 million of fixed-asset impairments, a $2.9 million impairment of a minority investment, $1.7 million of legal settlement and related costs, and $0.5 million of employee termination costs.
- Year-to-date operating cash flow declined to $19.6 million from $61.0 million, primarily due to lower profits and increased inventory. Inventory was built to support expected Security and Healthcare sales, including products shipped to customers for which revenue had not yet been recognized.
- Financing activities provided $22.5 million year to date, principally reflecting $55.0 million of revolving-credit borrowings. The company repurchased common stock and settled equity-award tax obligations using a combined $35.7 million of cash.
Guidance, Outlook, Risks, and Unusual Items
Management did not provide specific quantitative revenue or earnings guidance in the filing. Management stated that available cash, credit facilities, and expected operating cash flow should be sufficient to meet operational needs for at least the next 12 months.
Management expects continued potential delays or deferrals in customer purchasing because of China’s economic slowdown, U.S. dollar strength, lower oil prices, and broader global economic uncertainty. The filing states that the magnitude and duration of these effects cannot be quantified.
- Customer concentration is material: the Mexican tax authority, SAT, represented 14% of quarterly revenue and 15% of year-to-date revenue. A different customer represented 11% of accounts receivable at December 31, 2015.
- Approximately 97% of cash was held by foreign subsidiaries and may be subject to repatriation tax considerations.
- A $37.5 million customer advance related to the Mexican turnkey security-screening agreement remained outstanding and is scheduled to be fully amortized by the end of fiscal 2017.
- Approximately $16 million of fixed assets related to turnkey security operations in Mexico were not currently in use at December 31, 2015.
- The company faces contingent acquisition payments capped at $22 million, with $11.8 million recorded as contingent payment obligations at period-end.
- The $15.0 million securities class-action settlement received final court approval on December 21, 2015. The company expects the settlement to be fully funded by insurance. Related shareholder derivative actions remain pending, and their timing and outcome cannot be predicted.
- Environmental investigations continue at the Hawthorne, California facility concerning historical soil and groundwater contamination. No liability was accrued because management did not consider a loss probable and reasonably estimable, but an adverse resolution could materially affect the company.
- The company identified foreign currency, interest-rate, government spending and procurement, contract delays, customer acceptance, regulatory compliance, export controls, and litigation as significant risks.
- The company maintained an interest-rate swap maturing in October 2019 and reported no material change in market risk from the prior Form 10-K.
Important Facts for Investors to Verify
- Whether Security revenue stabilizes after the substantial completion of the FMS contract and whether replacement contract awards offset the resulting revenue gap.
- Whether elevated inventory converts into recognized revenue and cash without additional write-downs or margin pressure.
- The sustainability of liquidity after the $55.0 million increase in revolving-credit borrowings and the effect of variable interest rates.
- The collectability and timing of the SAT-related advance, deferred revenue, and customer receivables.
- The ultimate insurance funding of the securities settlement and potential exposure from the derivative litigation, environmental matters, and other contingencies.
- Whether global economic weakness, currency movements, lower oil prices, and government procurement delays continue to affect Healthcare and Optoelectronics demand.
- The company’s future accounting impact from the pending adoption of the revised revenue-recognition standard and other accounting updates.